Pierre L. Beaulieu

4.3k total citations
79 papers, 2.6k citations indexed

About

Pierre L. Beaulieu is a scholar working on Organic Chemistry, Hepatology and Infectious Diseases. According to data from OpenAlex, Pierre L. Beaulieu has authored 79 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Organic Chemistry, 33 papers in Hepatology and 31 papers in Infectious Diseases. Recurrent topics in Pierre L. Beaulieu's work include Hepatitis C virus research (33 papers), HIV/AIDS drug development and treatment (31 papers) and Biochemical and Molecular Research (12 papers). Pierre L. Beaulieu is often cited by papers focused on Hepatitis C virus research (33 papers), HIV/AIDS drug development and treatment (31 papers) and Biochemical and Molecular Research (12 papers). Pierre L. Beaulieu collaborates with scholars based in Canada, Germany and Egypt. Pierre L. Beaulieu's co-authors include James Gillard, Bruno Haché, Dominik Wernic, George Kukolj, Derrick L. J. Clive, Jean‐Simon Duceppe, Ginette McKercher, Youla S. Tsantrizos, Yves Bousquet and Jean Gauthier and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Pierre L. Beaulieu

78 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre L. Beaulieu Canada 32 1.3k 796 767 640 539 79 2.6k
Michael J. Sofia United States 32 1.1k 0.8× 1.7k 2.1× 1.1k 1.5× 1.2k 1.8× 1.0k 1.9× 122 3.8k
Bertil Samuelsson Sweden 34 1.6k 1.3× 1.6k 2.0× 385 0.5× 843 1.3× 351 0.7× 134 3.6k
Frank Narjes Italy 29 580 0.4× 564 0.7× 1.3k 1.7× 785 1.2× 731 1.4× 62 2.2k
Franck Amblard United States 22 1.4k 1.1× 1.2k 1.5× 349 0.5× 878 1.4× 524 1.0× 87 3.0k
Montse Llinàs‐Brunet Canada 25 497 0.4× 502 0.6× 908 1.2× 571 0.9× 421 0.8× 51 1.6k
Youla S. Tsantrizos Canada 28 679 0.5× 946 1.2× 397 0.5× 373 0.6× 217 0.4× 83 1.9k
Kent D. Stewart United States 34 967 0.7× 1.3k 1.6× 300 0.4× 559 0.9× 518 1.0× 91 3.1k
Peter S. Dragovich United States 27 876 0.7× 1.0k 1.3× 221 0.3× 460 0.7× 424 0.8× 77 2.8k
Viyyoor Girijavallabhan United States 23 736 0.6× 648 0.8× 282 0.4× 383 0.6× 231 0.4× 100 1.6k
Warren M. Kati United States 32 661 0.5× 1.6k 2.0× 724 0.9× 1.4k 2.2× 993 1.8× 81 3.5k

Countries citing papers authored by Pierre L. Beaulieu

Since Specialization
Citations

This map shows the geographic impact of Pierre L. Beaulieu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre L. Beaulieu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre L. Beaulieu more than expected).

Fields of papers citing papers by Pierre L. Beaulieu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre L. Beaulieu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre L. Beaulieu. The network helps show where Pierre L. Beaulieu may publish in the future.

Co-authorship network of co-authors of Pierre L. Beaulieu

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre L. Beaulieu. A scholar is included among the top collaborators of Pierre L. Beaulieu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre L. Beaulieu. Pierre L. Beaulieu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beaulieu, Pierre L., Gordon T. Bolger, Martin Duplessis, et al.. (2015). Multi-parameter optimization of aza-follow-ups to BI 207524, a thumb pocket 1 HCV NS5B polymerase inhibitor. Part 2: Impact of lipophilicity on promiscuity and in vivo toxicity. Bioorganic & Medicinal Chemistry Letters. 25(5). 1140–1145. 5 indexed citations
2.
Beaulieu, Pierre L., Gordon T. Bolger, Martin Duplessis, et al.. (2014). Aza follow-ups to BI 207524, a thumb pocket 1 HCV NS5B polymerase inhibitor. Part 1: Mitigating the genotoxic liability of an aniline metabolite. Bioorganic & Medicinal Chemistry Letters. 25(5). 1135–1139. 7 indexed citations
3.
Beaulieu, Pierre L., Catherine Chabot, Jianmin Duan, et al.. (2011). Indole 5-carboxamide Thumb Pocket I inhibitors of HCV NS5B polymerase with nanomolar potency in cell-based subgenomic replicons (part 2): Central amino acid linker and right-hand-side SAR studies. Bioorganic & Medicinal Chemistry Letters. 21(12). 3664–3670. 7 indexed citations
4.
Beaulieu, Pierre L.. (2010). Filibuvir, a non-nucleoside NS5B polymerase inhibitor for the potential oral treatment of chronic HCV infection.. PubMed. 13(12). 938–48. 11 indexed citations
5.
Beaulieu, Pierre L., James Gillard, Christian Brochu, et al.. (2010). N-Acetamideindolecarboxylic acid allosteric ‘finger-loop’ inhibitors of the hepatitis C virus NS5B polymerase: discovery and initial optimization studies. Bioorganic & Medicinal Chemistry Letters. 20(3). 857–861. 12 indexed citations
6.
Poirier, Martin, et al.. (2010). Metal-Free Coupling of Azoles with 2- and 3-Haloindoles Providing Access to Novel 2- or 3-(Azol-1-yl)indole Derivatives. Organic Letters. 12(10). 2334–2337. 38 indexed citations
7.
Beaulieu, Pierre L., Nathalie Dansereau, Jianmin Duan, et al.. (2010). Benzimidazole Thumb Pocket I finger-loop inhibitors of HCV NS5B polymerase: Improved drug-like properties through C-2 SAR in three sub-series. Bioorganic & Medicinal Chemistry Letters. 20(6). 1825–1829. 8 indexed citations
8.
Beaulieu, Pierre L.. (2006). Finger loop inhibitors of the HCV NS5B polymerase: discovery and prospects for new HCV therapy.. PubMed. 9(5). 618–26. 17 indexed citations
9.
Beaulieu, Pierre L., James Gillard, Murray D. Bailey, et al.. (2005). Synthesis of (1R,2S)-1-Amino-2-vinylcyclopropanecarboxylic Acid Vinyl-ACCA) Derivatives:  Key Intermediates for the Preparation of Inhibitors of the Hepatitis C Virus NS3 Protease. The Journal of Organic Chemistry. 70(15). 5869–5879. 65 indexed citations
10.
Kukolj, George, Graham A. McGibbon, Ginette McKercher, et al.. (2005). Binding Site Characterization and Resistance to a Class of Non-nucleoside Inhibitors of the Hepatitis C Virus NS5B Polymerase. Journal of Biological Chemistry. 280(47). 39260–39267. 100 indexed citations
11.
Beaulieu, Pierre L. & Youla S. Tsantrizos. (2004). Inhibitors of the HCV NS5B polymerase: new hope for the treatment of hepatitis C infections.. PubMed. 5(8). 838–50. 42 indexed citations
12.
Beaulieu, Pierre L., Michael Bös, Yves Bousquet, et al.. (2003). Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivatives. Bioorganic & Medicinal Chemistry Letters. 14(1). 119–124. 82 indexed citations
13.
14.
Beaulieu, Pierre L., James Gillard, Murray D. Bailey, et al.. (1999). Practical Synthesis of BILA 2157 BS, a Potent and Orally Active Renin Inhibitor:  Use of an Enzyme-Catalyzed Hydrolysis for the Preparation of Homochiral Succinic Acid Derivatives. The Journal of Organic Chemistry. 64(18). 6622–6634. 25 indexed citations
15.
Beaulieu, Pierre L. & Dominik Wernic. (1996). Preparation of Aminoalkyl Chlorohydrin Hydrochlorides:  Key Building Blocks for Hydroxyethylamine-Based HIV Protease Inhibitors. The Journal of Organic Chemistry. 61(11). 3635–3645. 89 indexed citations
16.
Tong, Liang, Susan Pav, Daniel Lamarre, et al.. (1995). Crystal structures of HIV-2 protease in complex with inhibitors containing the hydroxyethylamine dipeptide isostere. Structure. 3(1). 33–40. 38 indexed citations
17.
Liuzzi, Michel, Robert Déziel, Pierre L. Beaulieu, et al.. (1994). A potent peptidomimetic inhibitor of HSV ribonucleotide reductase with antiviral activity in vivo. Nature. 372(6507). 695–698. 109 indexed citations
18.
Hanessian, Stephen, et al.. (1987). Synthesis of carbocycles from ω-substituted α,β-unsaturated esters via radical-induced cyclizations. Canadian Journal of Chemistry. 65(8). 1859–1866. 45 indexed citations
19.
Beaulieu, Pierre L., et al.. (1980). Electrophilic additions to allenes. VI. The role of steric versus electronic effects in the reactions of arenesulphenyl halides with allenes. Canadian Journal of Chemistry. 58(24). 2737–2744. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael J. Sofia Breakdown of academic impact, for papers by Bertil Samuelsson Breakdown of academic impact, for papers by Frank Narjes Breakdown of academic impact, for papers by Franck Amblard Breakdown of academic impact, for papers by Montse Llinàs‐Brunet Breakdown of academic impact, for papers by Youla S. Tsantrizos Breakdown of academic impact, for papers by Kent D. Stewart Breakdown of academic impact, for papers by Peter S. Dragovich Breakdown of academic impact, for papers by Viyyoor Girijavallabhan Breakdown of academic impact, for papers by Warren M. Kati
Rankless by CCL
2026